|
Form S-8
|
|
(Form Type)
|
|
INFINITY PHARMACEUTICALS, INC.
|
|
(Exact Name of Registrant as Specified in its Charter)
|
|
Security
Type |
Security
Class
Title
|
Fee
Calculation
Rule
|
Amount
Registered (1)
|
Proposed
Maximum
Offering
Price Per
Unit
|
Proposed
Maximum
Aggregate
Offering
Price
|
Fee Rate
|
Amount of
Registration
Fee
|
|
Equity
|
Common Stock, $0.001 par value per share
|
Other
|
6,500,000 shares(2)
|
$0.76(3)
|
$4,940,000 (3)
|
$92.70 per $1,000,000
|
$457.94
|
|
Total Offering Amounts
|
$4,940,000
|
$457.94
|
|||||
|
Total Fee Offsets
|
$0
|
||||||
|
Net Fee Due
|
$457.94
|
||||||
| (1) |
In accordance with Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent
dilution resulting from stock splits, stock dividends or similar transactions.
|
| (2) |
Consists of 6,500,000 shares issuable under the Infinity Pharmaceuticals, Inc. 2019 Equity Incentive Plan, as amended.
|
| (3) |
Estimated solely for the purpose of calculating the registration fee to Rules 457(c) and 457(h) of the Securities Act, and based upon the average of the high and low prices of the Registrant’s Common Stock as reported on the Nasdaq Global
Market on June 13, 2022.
|